Clinical Treatment of Viral Hemorrhagic Fevers (VHFs)

Key points

  • Healthcare providers should notify their health department and CDC to determine a patient's course of treatment.
  • FDA-approved therapeutics do not exist for most viral hemorrhagic fevers.
  • Supportive care is vital for patients with suspected or confirmed VHFs.
  • Special precautions are needed to safely provide care like hemodialysis to VHF patients.

Treatment options

Care precautions